A detailed history of Mark Asset Management LP transactions in Liquidia Corp stock. As of the latest transaction made, Mark Asset Management LP holds 25,500 shares of LQDA stock, worth $571,455. This represents 0.03% of its overall portfolio holdings.

Number of Shares
25,500
Holding current value
$571,455
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$11.99 - $19.3 $305,745 - $492,150
25,500 New
25,500 $317,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $1.44B
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Mark Asset Management LP Portfolio

Follow Mark Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mark Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Mark Asset Management LP with notifications on news.